Vicore Pharma (Sweden) Price on August 7, 2024
| VICO Stock | SEK 7.72 0.07 0.92% |
If you're considering investing in Vicore Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vicore Pharma stands at 7.72, as last reported on the 11th of December 2024, with the highest price reaching 7.76 and the lowest price hitting 7.57 during the day. Currently, Vicore Pharma Holding is slightly risky. Vicore Pharma Holding owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.06, which indicates the firm had a 0.06% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Vicore Pharma Holding, which you can use to evaluate the volatility of the company. Please validate Vicore Pharma's Risk Adjusted Performance of 0.0217, coefficient of variation of 5115.99, and Semi Deviation of 2.26 to confirm if the risk estimate we provide is consistent with the expected return of 0.18%.
Vicore Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vicore |
Sharpe Ratio = 0.06
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | VICO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.95 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Vicore Pharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vicore Pharma by adding it to a well-diversified portfolio.
Vicore Pharma Valuation on August 7, 2024
It is possible to determine the worth of Vicore Pharma on a given historical date. On August 7, 2024 Vicore was worth 17.02 at the beginning of the trading date compared to the closed value of 17.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vicore Pharma stock. Still, in general, we apply an absolute valuation method to find Vicore Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vicore Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vicore Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 17.52 | 17.80 | 16.96 | 17.04 | 160,920 | |
08/07/2024 | 17.02 | 17.50 | 16.92 | 17.22 | 60,568 |
| 17.20 | 17.26 | 16.90 | 17.20 | 152,296 |
| Backtest Vicore Pharma | | | Vicore Pharma History | | | Vicore Pharma Valuation | Previous | Next |
Vicore Pharma Trading Date Momentum on August 7, 2024
| On August 08 2024 Vicore Pharma Holding was traded for 17.20 at the closing time. The highest price during the trading period was 17.26 and the lowest recorded bid was listed for 16.90 . The volume for the day was 152.3 K. This history from August 8, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 0.12% . The trading price change to the current price is 1.16% . |
Vicore Pharma Holding Fundamentals Correlations and Trends
By evaluating Vicore Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vicore Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vicore financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vicore Pharma Stock history
Vicore Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vicore is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vicore Pharma Holding will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vicore Pharma stock prices may prove useful in developing a viable investing in Vicore Pharma
Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden.
Vicore Pharma Stock Technical Analysis
Vicore Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vicore Pharma Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Vicore Pharma Holding cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vicore Pharma December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Vicore Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vicore Pharma shares will generate the highest return on investment. By undertsting and applying Vicore Pharma stock market strength indicators, traders can identify Vicore Pharma Holding entry and exit signals to maximize returns
Vicore Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vicore Pharma's price direction in advance. Along with the technical and fundamental analysis of Vicore Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vicore to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0217 | |||
| Jensen Alpha | 0.0998 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.